Age ≥18 years old |
Breast micro-calcifications prior to starting radiation treatment (RT) |
ECOG performance status of 0–1 |
> 9 positive axillary or sentinel lymph node |
Stage 0–IIIA (pTis-T2, pN0-pN2a, M0) breast cancer |
Lobular carcinoma in situ alone or non breast epithelial histology |
Systemic treatment (chemotherapy or hormonal therapy) was allowed. |
Multicentric disease |
Neoadjuvant chemotherapy allowed. |
Clinically or radiographically suspicious contralateral regional lymph nodes unless histologically confirmed negative for tumor |
Negative margins (no tumor on ink). |
Prior treatment for contralateral or synchronous breast cancer or if they had prior RT to the current breast. |
Co-morbid conditions:
Paget’s disease
Collagen vascular disease
Life expectancy <2 years secondary to co-morbidities
Psychiatric or addictive disorder that precluded informed consent
Malignancy other than non-melanomatous skin cancer < 5 years prior to enrollment
|
No documented negative pregnancy test or unwilling to maintain safe and effective birth control |